Drugs / DWP712
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT06212960 | Nov 2023 → Feb 2024 | — | Daewoong Pharmaceutical Co. LTD. | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT07013279 | Jul → Dec 2025 overdue | — | Daewoong Pharmaceutical Co. LTD. | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DWP712 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06212960 ↗ |